Cargando…

Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients

BACKGROUND: In polypharmacy patients, medication therapy management (MTM) services provide a comprehensive review of current medications and future treatment goals. Pharmacogenetics (PGx) may further optimize the identification of potential drug therapy problems (DTPs); however, the clinical utility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kibum, Magness, Jonathan W., Nelson, Ryan, Baron, Valerie, Brixner, Diana I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397798/ https://www.ncbi.nlm.nih.gov/pubmed/30479202 http://dx.doi.org/10.18553/jmcp.2018.24.12.1250

Ejemplares similares

Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial
por: Elliott, Lindsay S., et al.
Publicado: (2017)

FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy
por: Roncato, Rossana, et al.
Publicado: (2019)

“Black box” pharmacogenetic decision-support tools in psychiatry
por: Bousman, Chad A., et al.
Publicado: (2020)

Polypharmacy - is there a cure for drug therapy problems?
por: Orehovački, Helena, et al.
Publicado: (2023)

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

Correction to: Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

S222. CLINICAL UTILITY OF PHARMACOGENETIC TESTING IN SCHIZOPHRENIA TREATMENT
por: Mueller, Daniel, et al.
Publicado: (2018)

Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
por: Malsagova, Kristina A., et al.
Publicado: (2020)

Pharmacogenetics of Hypoglycemia Associated with Sulfonylurea Therapy in Usual Clinical Care
por: Mitchell, Sabrina L, et al.
Publicado: (2020)

Pharmacogenetics in the clinic
por: Guchelaar, H.-J.
Publicado: (2013)

Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic
por: Claudio‐Campos, Karla, et al.
Publicado: (2020)

Pharmacogenetics of antipsychotic therapy: pivotal research issues and the prospects for clinical implementation
por: Lerer, Bernard, et al.
Publicado: (2006)

Using an Electronic Decision Support Tool to Reduce Inappropriate Polypharmacy and Optimize Medicines: Rationale and Methods
por: Young, Amber, et al.
Publicado: (2016)

Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review
por: Aboelbaha, Shimaa, et al.
Publicado: (2021)

Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders
por: Blasco-Fontecilla, Hilario
Publicado: (2018)

Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings
por: Smith, D. Max, et al.
Publicado: (2020)

Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms
por: Keine, Dorothy, et al.
Publicado: (2019)

The utility of pharmacogenetic testing to support the treatment of bipolar disorder
por: Ielmini, Marta, et al.
Publicado: (2018)

Clinical Utility of Medication-Based Risk Scores to Reduce Polypharmacy and Potentially Avoidable Healthcare Utilization
por: Silva-Almodóvar, Armando, et al.
Publicado: (2022)

Pharmacogenetics aspects of oral anticoagulants therapy
por: Militaru, FC, et al.
Publicado: (2015)

Pharmacogenetics Update on Biologic Therapy in Psoriasis
por: Muñoz-Aceituno, Ester, et al.
Publicado: (2020)

Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner's perspective
por: Stawicki, Stanislaw P., et al.
Publicado: (2015)

Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with Polypharmacy
por: Sugarman, Elaine A., et al.
Publicado: (2016)

Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study
por: Finkelstein, Joseph, et al.
Publicado: (2016)

Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report
por: Jessop, Jayson P., et al.
Publicado: (2023)

Proposal for a Pharmacogenetic Decision Algorithm
por: Alzghari, Saeed K, et al.
Publicado: (2017)

Association Studies in Clinical Pharmacogenetics
por: Zubiaur, Pablo, et al.
Publicado: (2022)

Standardizing Quality Assessment of Observational Studies for Decision Making in Health Care
por: Brixner, Diana
Publicado: (2009)

Tools supporting polypharmacy management in Italy: Factors determining digital technologies' intention to use in clinical practice
por: Catrini, Elisabetta, et al.
Publicado: (2022)

Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical Case Report
por: Smith, Teri, et al.
Publicado: (2015)

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease
por: Dulai, Parambir S., et al.
Publicado: (2019)

HIV therapy in an ageing population — the challenge of polypharmacy
por: Back, DJ
Publicado: (2010)

The Potential Utility of Pharmacogenetic Testing in Psychiatry
por: Gardner, Kathryn R., et al.
Publicado: (2014)

The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021)

Pharmacogenetics of cancer therapy: breakthroughs from beyond?
por: Lu, Da-Yong, et al.
Publicado: (2015)

Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases
por: Krasi, Geraldo, et al.
Publicado: (2019)

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
por: Radosavljevic, Milica, et al.
Publicado: (2023)

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC(®)) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
por: Blazy, Christopher, et al.
Publicado: (2022)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds
por: Hendershot, Christian S
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_26terakbc7d4mqu6q0k00qtno8